رجوع
نطاق اليوم
KWD 11.71
KWD 12.13
نطاق 52 أسبوعًا
KWD 6.69
KWD 15.42
حجم التداول
3,805,135
متوسط 50 يوم / 200 يوم
KWD 13.66
/
KWD 10.91
الإغلاق السابق
KWD 11.92
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 52.7 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 2.4 | 3.9 |
| Rev Growth 5Y % | 9.6 | 10.0 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 16.000
+32.6%
Low: KWD 15.000
High: KWD 17.000
مكرر الربحية المستقبلي
12.0
ربحية السهم المستقبلية
KWD 0.990
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.1 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 1.373
KWD 1.362 – KWD 1.387
|
3.5 B | 1 |
| FY2027 |
KWD 1.176
KWD 1.125 – KWD 1.237
|
3.3 B | 3 |
| FY2026 |
KWD 0.990
KWD 0.980 – KWD 1.000
|
3.1 B | 3 |
النقاط الرئيسية
Revenue grew 9.58% annually over 5 years — modest growth
Generating 269.93M in free cash flow
P/E of 52.70 — premium valuation
Cash machine — converts 374.60% of earnings into free cash flow
Capital efficient — spends only 2.32% of revenue on capex
Interest coverage of 1.75× — tight debt servicing
النمو
Revenue Growth (5Y)
9.58%
Revenue (1Y)8.05%
Earnings (1Y)N/A
FCF Growth (3Y)-1.18%
الجودة
Return on Equity
N/A
ROIC11.90%
Net Margin2.39%
Op. Margin14.02%
الأمان
Debt / Equity
N/A
Current Ratio2.17
Interest Coverage1.75
التقييم
P/E Ratio
52.70
P/B RatioN/A
EV/EBITDA14.71
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.05% | Revenue Growth (3Y) | 12.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.58% | Earnings Growth (5Y) | 61.38% |
| Profitability | |||
| Revenue (TTM) | 3.02B | Net Income (TTM) | 72.06M |
| ROE | N/A | ROA | 1.96% |
| Gross Margin | 37.63% | Operating Margin | 14.02% |
| Net Margin | 2.39% | Free Cash Flow (TTM) | 269.93M |
| ROIC | 11.90% | FCF Growth (3Y) | -1.18% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.17 |
| Interest Coverage | 1.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 52.70 | P/B Ratio | N/A |
| P/S Ratio | 1.26 | PEG Ratio | -0.34 |
| EV/EBITDA | 14.71 | Dividend Yield | 0.00% |
| Market Cap | 3.80B | Enterprise Value | 6.22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.02B | 2.79B | 2.39B | 2.21B | 2.09B |
| Net Income | 72.06M | -116.89M | -83.99M | -129.99M | 10.62M |
| EPS (Diluted) | 0.22 | -0.38 | -0.48 | -0.86 | 0.07 |
| Gross Profit | 1.14B | 1.02B | 863.87M | 791.46M | 768.97M |
| Operating Income | 423.09M | 249.33M | 204.37M | -94.93M | 152.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B |
| Total Liabilities | 3.67B | 3.55B | 3.41B | 3.59B | 3.57B |
| Shareholders' Equity | -70.79M | -109.27M | 19.78M | 298.42M | 360.34M |
| Total Debt | 2.74B | 2.59B | 2.75B | 2.85B | 2.88B |
| Cash & Equivalents | 310.87M | 110.55M | 91.54M | 25.98M | 247.79M |
| Current Assets | 1.91B | 1.59B | 1.38B | 1.41B | 1.52B |
| Current Liabilities | 881.63M | 1.13B | 846.60M | 752.80M | 677.24M |